COMMUNIQUÉS West-GlobeNewswire

Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
28/07/2026
Leading neurologists and researchers to provide strategic and clinical guidance as Slate Medicines progresses SLTE-1009 and a broader pipeline of migraine therapeutics. RALEIGH, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
28/07/2026
BRIDGEWATER N.J., July 28, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, [...]
Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments
28/07/2026
Positive proof-of-concept clinical data show substantial improvements in visual acuity in limbal stem cell deficiency ( LSCD) patients treated with CSB-001 Pivotal studies for CSB-001 in LSCD planned for 1H 2027 Series [...]
Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome
28/07/2026
Rugonersen, a potentially best-in-class antisense oligonucleotide (ASO) therapy in development for Angelman syndrome, advanced into the pivotal Phase 3 BEACON clinical trial Angelman syndrome affects approximately 30, [...]
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
28/07/2026
Company expects to initiate enrollment in TEMPO-1 in September 2026 OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the 2L setting in the U.S. with approximately 14,000 patients eligible annually [...]
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
28/07/2026
SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended [...]
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
28/07/2026
The six-month pilot is designed to evaluate the potential scalability of bringing physician-ordered, blood-based OkaiDx laboratory-developed tests to patients in Canada Taipei, Taiwan, July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their [...]
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
28/07/2026
Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived [...]
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
28/07/2026
– ARCALYST ® (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth – – ARCALYST 2026 expected net product revenue increased to $980 - $995 million – – KPL-387 Phase 2 data [...]
Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents
28/07/2026
Filmmakers across more than 50 countries submitted work on loss and healing, signaling cinema's growing power as a shared language for grief. New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- Grief Fest™ , the first [...]
Transactions in connection with share buy-back program
28/07/2026
Company announcement no. 27 - 26 28 July 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
28/07/2026
No ARIA-E observed across all genotypes, including APOE4 homozygotes ARIA-H tracking background rates Early biomarker movement consistent with target engagement 12-month topline results expected in Q1 2027 Cambridge, [...]
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
28/07/2026
New investor Horizon 3 Healthcare led the round, which was supported by the European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita and other current shareholders Builds on the €50m secured in [...]
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
28/07/2026
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC Non-dilutive Biomedical Catalyst funding from Innovate UK will support the advancement of [...]
Aqua free Supports Drinking Water Project in Tanzania
28/07/2026
Hamburg, 28.07.2026 - Access to safe water is still not given in many parts of the world. In Lower Moshi, a region south of Mount Kilimanjaro in Tanzania, communities and schools struggle with contaminated drinking [...]
Aqua free soutient un projet d’accès à l’eau potable en Tanzanie
28/07/2026
Hamburg, 28.07.2026 - Dans de nombreuses régions du monde, l’accès à une eau potable sûre est encore loin d’être garanti. Dans le Lower Moshi, une région située au sud du Kilimandjaro, en Tanzanie, les communautés [...]
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
28/07/2026
Good-to-excellent cosmetic outcomes 30 of 94 patients enrolled have now reached 24 months of follow-up High surgeon satisfaction sustained through study to date Improvements in patient-reported breast satisfaction and [...]
Rapid Nutrition Expands Owned-Brand Portfolio Through AI-Driven Commercial Intelligence
28/07/2026
Initial rollout of the Premium Nutrition Pantry demonstrates the Company's strategy to accelerate owned-brand expansion, strengthen vertical integration and support long-term revenue growth LONDON, July 28, 2026 (GLOBE [...]

Pages